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Cellular/Molecular
Mitochondrial Exchanger NCLX Plays a Major Role in the
Intracellular Ca2 Signaling, Gliotransmission, and
Proliferation of Astrocytes
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Mitochondria not only provide cells with energy, but are central to Ca2 signaling. Powered by the mitochondrial membrane potential,
Ca2 enters themitochondria and is released into the cytosol through amitochondrial Na/Ca2 exchanger.We established thatNCLX,
a newly discoveredmitochondrialNa/Ca2 exchanger, is expressed in astrocytes isolated frommice of either sex. Immunoblot analysis
of organellar fractions showed that the location ofNCLX is confined tomitochondria. Using pericam-basedmitochondrial Ca2 imaging
and NCLX inhibition either by siRNA or by the pharmacological blocker CGP37157, we demonstrated that NCLX is responsible for
mitochondrial Ca2 extrusion. Suppression of NCLX function altered cytosolic Ca2 dynamics in astrocytes and this wasmediated by a
strong effect of NCLX activity on Ca2 influx via store-operated entry. Furthermore, Ca2 influx through the store-operated Ca2 entry
triggered strong,whereas ERCa2 release triggered onlymodestmitochondrial Ca2 transients, indicating that the functional cross talk
between the plasma membrane and mitochondrial domains is particularly strong in astrocytes. Finally, silencing of NCLX expression
significantly reduced Ca2-dependent processes in astrocytes (i.e., exocytotic glutamate release, in vitro wound closure, and prolifera-
tion), whereas Ca2wave propagation was not affected. Therefore, NCLX, bymeditating astrocytic mitochondrial Na/Ca2 exchange,
links betweenmitochondria andplasmamembraneCa2 signaling, therebymodulating cytoplasmicCa2 transients required to control
a diverse array of astrocyte functions.
Introduction
Ca2 signaling is central for the regulation of astrocyte functions
and for interastrocytic and astrocyte–neuron communication.
Neuronal activity, via the activation of metabotropic receptors,
triggers transient increases in the cytosolic Ca2 concentration in
astrocytes that leads to the release of gliotransmitters such as ATP
and glutamate, which can signal to adjacent neurons (Agulhon et
al., 2008; Perea et al., 2009). Astrocytic Ca2 transients after
metabotropic receptor activation are initiated by release of Ca2
from the ER stores and by the entry from the extracellular space
through store-operated Ca2 channels. The spatiotemporal pat-
tern of cytoplasmic Ca2 signals is dynamically organized and
allows for a great complexity of astrocytic Ca2 responses.
Mitochondria, in addition to their metabolic role, participate
in intracellular Ca2 signaling via dynamic buffering and shut-
tling cytosolic Ca2. Powered by the mitochondrial membrane
potential, Ca2 enters mitochondria via the mitochondrial uni-
porter (Baughman et al., 2011; De Stefani et al., 2011; Pizzo et al.,
2012) and is extruded frommitochondria via Na-dependent or
-independent pathways (Drago et al., 2011). Mitochondria rap-
idly sense cellularCa2 signals and act as local Ca2 buffers in the
vicinity of Ca2 release sites such as the ER or plasmamembrane
Ca2 channels. By buffering and shuttling Ca2, they modulate
local and bulk cytoplasmic Ca2 changes (Szabadkai and
Duchen, 2008; Contreras et al., 2010), thereby controlling cell-
type-specific functions. Different cell types may vary with regard
to mitochondrial Ca2 handling, in particular Ca2 extrusion
mechanisms (Pizzo et al., 2012). At the neuronal synapse, for
example, themitochondrial Na/Ca2 exchanger participates in
shapingCa2 signals, thusmodulating neuronal activity and syn-
aptic plasticity (Kann and Kova´cs, 2007; Pizzo et al., 2012). Ac-
tivity of the mitochondrial exchanger has also been documented
in astrocytes, where it is closely linked to exocytotic release of
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glutamate and mediates a robust cytosolic and mitochondrial
Na transport (Bernardinelli et al., 2006; Reyes and Parpura,
2008; Verkhratsky et al., 2012).
The benzothiazepine CGP37157 effectively blocks the activity
of the mitochondrial exchanger. However, CGP37157, like other
benzothiazepines, also modulates the activity of other Ca2
channels and transporters that participate in glial Ca2 signaling,
among them SERCA, L-type, and the store-operated channels
(Czyz and Kiedrowski, 2003; Thu le et al., 2006; Neumann et al.,
2011). Molecular tools that selectively control the exchanger’s
activity or expression were not available because the identity of
the mitochondrial exchanger gene was unknown. We have re-
cently found thatmitochondrial Na/Ca2 exchange can beme-
diated by a member of the Na/Ca2 exchanger superfamily,
NCLX (Palty et al., 2010), and devised siRNA-based tools that
control NCLX activity and thus can demonstrate its impact on
mitochondrial and global cellular Ca2 dynamics.
In the present study, we show that NCLX is themitochondrial
exchanger in astrocytes and plays a distinct role in controlling the
ER- versus store-operated channel-dependent Ca2 signals in
astrocytes. By differentially controlling these Ca2 signaling
pathways, NCLX plays an essential role in facilitating a diverse
array of astrocytic cellular activities ranging from release of glu-
tamate to wound healing and proliferation.
Materials andMethods
Astrocyte cell culture
Procedures for animal work were approved by the Federal Ministry of
Berlin (Landesamt fu¨r Gesundheit und Soziales) or the University of
Alabama-Birmingham institutional animal care and use committee.
Enriched astrocyte cultures were prepared from cortices of 0- to 2-d-
old newborn Naval Medical Research Institute mice or C57BL/6 mice of
either sex, as described previously (Lyons and Kettenmann, 1998).
Briefly, mice were killed by decapitation and cortical tissue was carefully
freed from blood vessels andmeninges, trypsinized, and gently triturated
with a fire-polished pipette in the presence of 0.05% DNase (Worthing-
ton Biochem). After two washes, cells were cultured in DMEMwith 10%
fetal calf serum inPetri dishes (10 cm in diameter), in 25 cm2 flasks, or on
poly-L-lysine-coated glass coverslips at 37°C in a humidified 5% CO2/
95% air atmosphere. After 1 d, cells were washed twice with HBSS to
remove cellular debris.
For glutamate release experiments and the associated subset of
calcium-imaging experiments, astrocyte cultures were prepared from
visual cortices of 0- to 2-d-old C57BL/6 mice of either sex as described
previously (Reyes et al., 2011). Astrocytes were grown in culturemedium
containing -MEMwithout phenol red (Invitrogen) supplemented with
fetal bovine serum (10%v/v; Thermo ScientificHyclone), L-glutamine (2
mM), D-glucose (20 mM), sodium pyruvate (1 mM), penicillin (100 I.U./
ml), streptomycin (100 g/ml), and sodium bicarbonate (14 mM), pH
7.35. After 7–18 d in culture, cells were purified for astrocytes (99% for
the astrocytes from visual cortices). In some cases, after the purification
procedure, astrocytes were returned to the incubator up to 1 d before
transfection.
Reagents and plasmids
CGP37157 (7-chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiaz-
epin-2( 3H )-one; Ascent Scientific) was freshly prepared before each ex-
periment at a stock concentration of 40 mM in DMSO and was used at a
final concentration of 20 M. ATP and all other reagents were obtained
from Sigma-Aldrich.
The plasmid expressing mitochondrial-targeted ratiometric-pericam
(pcDNA3.1-mtRP) was kindly provided by Atsushi Miyawaki (Wako,
Japan). Double-stranded ON-TARGETplus SMARTpool siRNAs, used
to silence NCLX expression, and siGLORISC-Free siRNAwere obtained
from Dharmacon or Thermo Fisher Scientific.
Transfection procedures
For silencing NCLX expression, astrocytes were transfected with an ON-
TARGET mixture of siRNAs (siNCLX) or a pool of control ON-
TARGETplus nontargeting siRNAs (siControl) at a final concentration
of 10 nM siRNA. As additional controls, in some experiments, cells were
treated only with a transfection reagent (mock-treated) or untreated.
Astrocytes were analyzed 3 d after the transfection. Lipofectamine
RNAiMAX (1 l/1200 l of medium; Invitrogen) or TransIT-TKO (6
l/flask containing 4 ml of medium;Mirus) was used to transfect astro-
cytes with siRNA. The fluorescent transfectionmarker siGLO RISC-Free
siRNA was used in the cytoplasmic Ca2-imaging experiments and glu-
tamate release experiments to identify siRNA-transfected cells. Analysis
of siGLO fluorescence, visualized using a standard tetramethylrhod-
amine isothiocyanate filter set (Chroma Technology), indicated that
siRNA was delivered to all astrocytes and retained intracellularly
throughout the duration of experiments.
To determine mitochondrial Ca2 responses after knock-down of
NCLX expression in astrocytes, the siNCLX or control siRNAs (siCon-
trol) were cotransfected with pcDna3.1-mtRP (1 g) using Lipo-
fectamine 2000 (1 l/each 300 l of medium; Invitrogen) according to
the manufacturer’s protocol. Transfection efficiency was1–5%. Mito-
chondrial expression of the pericam sensor mtRP was documented in a
two-photon laser scanning microscope (Till Photonics) equipped with a
water-immersion objective (40, numerical aperture [NA] 0.8; Olym-
pus). mtRP was excited by a Chameleon Ultra II laser (Coherent) set to a
wavelength of 920 nm, and z-stacks of 150 150 m images with a step
size of 2 m were acquired.
Cell fractionation and Western blot analysis
Cell/tissue lysis. Astrocytic monolayers or homogenized total brains were
lysed with RIPA buffer (Sigma-Aldrich) supplemented with protease in-
hibitors (Roche Diagnostics), agitated at 4°C for 30min, and centrifuged
for 20 min at 14,000 rpm. The supernatants were then collected and
frozen at70°C until use.
Subcellular fractionation. ER, cytosol, and mitochondria-enriched
fractions fromprimary astroglia cultures were obtained as described pre-
viously (Bozidis et al., 2007). Briefly,4–5 107 cells were washed once
with PBS, suspended inMTE solution (270 mM D-mannitol, 10 mM Tris,
0.1 mM EDTA, pH 7.4), and then lysed by sonication. The homogenate
was centrifuged at 1400 g for 10 min and the supernatant (total frac-
tion)was recovered and further centrifuged for 10min at 15,000 g. The
resulting pellet (crude mitochondria) and supernatant (crude ER) were
separated for further purification, loaded on the top of a sucrose gradi-
ent, centrifuged, isolated, and washed once. Pellets were resuspended in
PBS and frozen at70°C until use.
The plasma-membrane-enriched fractionwas purified using a cell sur-
face protein isolation kit (Pierce/Thermo Fisher Scientific) according to
the manufacturer’s instructions.
Protein quantification and immunoblotting. Protein concentration was
determined using the BCA assay (Pierce/Thermo Fisher Scientific). First,
the plasma-membrane-enriched fraction was dialyzed 3 times in 2 L of
PBS and then assayed using the BCA method. Extracted proteins (20
g/lane) were separated on 10% or 12% SDS-PAGE and transferred
onto polyvinylidene difluoride membrane (GE Healthcare Europe).
Membranes were probed using the following antibodies: polyclonal
anti-NCLX (1:1000; Palty et al., 2004), anti-GAPDH (1:10,000; New
England Biolabs), anti-ANT (1:100; Santa Cruz Biotechnology), anti-
Sec62 (1:1000; kindly provided by Prof. Dr. T. Sommer, Max Del-
bru¨ck Center for Molecular Medicine, Berlin), and anti-N-cadherin
(1:1000; BD Biosciences).
Real-time quantitative RT-PCR
Efficacy of silencing was determined by real-time quantitative RT-PCR
analysis, which was performed 3 d after the delivery of siRNA (as de-
scribed above). Astrocytes were harvested and total RNA was extracted
with the InviTrap Spin universal mini kit (Invitek) according to the
manufacturer’s instructions. This was followed by first-strand cDNA
synthesis using the SuperScript II reverse transcriptase enzyme (Invitro-
gen) with 1g of total RNA and oligo-dT primers. Quantitative RT-PCR
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was performed with gene-specific assays purchased from Dharmacon/
Thermo Fisher Scientific) according to the manufacturer’s instructions.
GAPDH served as the internal control to quantify relative changes in
gene expression.
Glutamate measurements in stimulated solitary astrocytes
Stimulation of astrocytes. To evoke an increase in cytosolic Ca2 of soli-
tary astrocytes and consequential exocytotic glutamate release, we me-
chanically stimulated astrocytes using glass pipettes filled with external
solution as described in detail previously (Hua et al., 2004). This ap-
proach has physiological relevance and allows spatiotemporal control of
the stimulus application without affecting plasma membrane integrity
(Hua et al., 2004; Malarkey and Parpura, 2011). To control for the con-
tact between the pipette and the solitary astrocyte, we monitored pipette
resistance using a patch-clamp amplifier (PC-ONE; Dagan). The
strength of the stimulus, measured as the increase in the pipette resis-
tance upon establishment of a pipette-astrocyte contact, was comparable
under all conditions tested (Mann–Whitney U test, p 0.27–0.34).
Glutamate measurements. Ca2-dependent glutamate release from
cultured solitary astrocytes was measured using the L-glutamate dehy-
drogenase (GDH)-linked assay as described previously (Hua et al., 2004;
Montana et al., 2004; Lee et al., 2008). Astrocytes were bathed in an
enzymatic assay solution containing external solution supplemented
with NAD (1 mM, catalog #N6522; Sigma-Aldrich) and GDH (53–
137 IU/ml, catalog #G2626; Sigma-Aldrich, pH 7.4). External solution
contained the following (in mM): 140 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 5
glucose, and 10HEPES, pH 7.4.When released to the extracellular space,
glutamate gets converted by GDH to -ketoglutarate with the concomi-
tant reduction of the bath supplied coenzyme NAD to NADH, the
latter being a fluorescent productwhen excited byUV light. Visualization
was achieved at room temperature (20–24°C) using a standard DAPI
filter set (Nikon). Every experiment was preceded by a sham run on
astrocytes bathed in solution lacking GDH and NAD for photobleach-
ing and background subtraction calculation. After correction, all imag-
ing data were expressed as dF/F0 (%), where dF represents the change of
fluorescence and F0 represents the background fluorescence level sur-
rounding the solitary astrocyte, immediately and laterally of its soma,
before mechanical stimulation. Imaging acquisition for these experi-
ments is described below as Ca2measurements in solitary astrocytes.
Fluorimetric measurements of cytosolic and mitochondrial Ca2
Cytosolic Ca2 levels in astrocytes were recorded using the Ca2 indi-
cators fura-2 AM or fluo-3 AM as described previously (Hua et al., 2004;
Montana et al., 2004; Lee et al., 2008). Subconfluent astrocytic monolay-
ers on coverslips were loaded for 30 min at room temperature with 2.5
M fura-2 AM (Invitrogen) in external solution (HEPES buffer; see be-
low), followed by at least a 20 min wash to allow de-esterification. Alter-
natively, solitary astrocytes were loaded with fluo-3 AM (1 g/ml;
Invitrogen) in external solution containing pluronic acid (0.025% w/v;
Invitrogen) for 20 min at room temperature, followed by washing in
external solution for 20 min at room temperature. Mitochondrial Ca2
levels were monitored in astrocytes transiently expressing mtRP. All
Ca2-imaging experiments were performed at room temperature. Cells
were transferred to the stage of an Axiovert 135 inverted microscope
(Carl Zeiss) equipped with a cooled CCD camera (PCO Imaging) and a
Polychrome V monochromator (TILL Photonics) and superfused with
3.5–4.0 ml/min Ca2-full HEPES buffer containing the following (in
mM):NaCl 150.0, KCl 5.4,MgCl2 1.0, CaCl2 2.0,HEPES 10.0, and glucose
10.0, pH 7.4). In Ca2-free HEPES buffer, 2 mM Ca2was replaced by 2
mM MgCl2 and 0.5 mM EGTA. Images were acquired through a 20
objective for cytoplasmic-imaging experiments using Axon Imaging
Workbench 6 software (INDEC BioSystems) at an acquisition rate of 1
frame/1.2 s. Fura-2 AM-loaded cells were excited at wavelengths of 340
and 380 nm and the emitted light passed through a long-pass emission
filter at 510 ( 40) nm.
Mitochondrial Ca2 levels were monitored in cells transiently ex-
pressing mtRP using a 40 objective at an excitation wavelength of 430
nm (Ca2-sensitive wavelength; Nagai et al., 2001) and 480 nm, pre-
sented as F0/F430 or R/R0 (r F480/F430). In some of the indicated exper-
iments described in the Results section, cell data were taken only at 430
nm because of significant fluorescence changes at 480 nm, likely related
to changes inmitochondrial pHi (Malli et al., 2003).When excited at 480
nm, mitochondrial pericam mtRP is strongly affected by pH, and the
excitation of mtRP at 480 nm was in fact previously used effectively for
monitoring mitochondrial pH changes (Jiang et al., 2009). Emitted light
of cells excited in either wavelength was collected using a 535 nm band-
pass filter. F0 was calculated as the average value obtained during the
50–100 s before the stimulus application.
Cytoplasmic Ca2 measurements in solitary astrocytes (associated
with glutamate measurements) were performed on an inverted micro-
scope (TE 300; Nikon) equipped with differential interference contrast
and wide-field fluorescence illumination (halogen and xenon arc lamps,
respectively). Visualization of fluo-3 AMwas accomplished using a stan-
dard FITC filter set (Chroma Technology). Images were captured
through a 40 fluor objective (NA 1.3; Nikon) using a CoolSNAP-HQ
cooled charge-coupled device camera (Photometrics) driven by V
imaging software (Digital Optics). For time-lapse image acquisition, a
camera and an electronic shutter (Vincent Associates) inserted in the
excitation pathway were controlled by the software. All imaging data
were background subtracted using regions of the coverslip field contain-
ing no cells. Data are expressed as dF/F0 SEM (%) in which dF repre-
sents the change of fluorescence and F0 represents the fluorescence of the
cell soma at rest.
Cell viability and nuclear staining
To test the effects that transfection agents and downregulation of NCLX
may have on viability of astrocytes, we assessed the ability of these cells to
accumulate the vital stain calcein (Hua et al., 2004). Cultured astrocytes
were incubated with calcein AM (1g/ml; Invitrogen) and pluronic acid
(0.025% w/v) in complete culture medium at 37°C in a humidified 5%
CO2/95%air atmosphere for 10min.De-esterification of calcein AMwas
permitted for 10 min by keeping astrocytes in external solution at room
temperature. During the last 5min, nuclei were stained by adding the cell
permeant nuclear stain Hoechst 33342 (5 g/ml; Invitrogen). Calcein
was visualized using the FITC filter set, and a DAPI filter set was used for
visualization of Hoechst. Image acquisition and processing was done as
reported above, except here we used a 60 Plan Apo oil-immersion
objective (1.4 NA; Nikon).
Astrocytic wound-healing assay
Astrocytic wound healing was evaluated using a scratch assay described
previously (Geba¨ck et al., 2009). One day after seeding into 4-well plates,
semiconfluent astrocytes were transfected with either 10 nM siNCLX-
silencing RNA, siControl or mock-transfected as described, or left un-
treated and cultured for 3 d to reach full confluence. At day 4, astrocytic
monolayers were scratchedwith a 200l sterile pipette tip in the shape of
a horizontal double cross (Fig. 7B). After two washes with PBS to remove
detached cells and debris, cells were incubated in serum-reduced medium
containing 1%FBS. Phase contrast images of thewoundswere acquired at
0–72 h after scratching using a 5 magnification objective and frame
grabber software (InteQ). At each acquisition time point, the culture dish
and the cross-shaped wound area was exactly centered and images were
acquired at identical positions (Fig. 7A,B). TScratch software (Geba¨ck et
al., 2009; www.cse-lab.ethz.ch/software) was used to determine the per-
centage area without cells at different time points (open wound area).
The final time point was defined as the time point when the initial open
wound area was closed by at least two-thirds (in untreated control). At
least six replicates per condition were analyzed and the results are ex-
pressed as the percentage open wound area.
Cell proliferation assay
Astrocyte proliferation was determined by a colorimetric immunoassay
measuring 5-bromodeoxyuridine (BrdU) incorporation (Roche Diag-
nostics) in proliferating cells. Two days after transfection of astrocytes
with siRNA, cells were trypsinized and seeded into 96-well plates at a
density of 3.5  103 cells/well. One day after the transfection, medium
was changed to medium containing 1% FCS and BrdU was added 3 d
after the transfection according to the manufacturer’s instructions. The
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assay was performed 24 h after the addition of BrdU according to the
manufacturer’s instructions with five replicates for each condition.
Astrocytic Ca2 waves
Confluent astrocytes grown on coverslips were loaded with 5 m fluo-4
AM for 30 min at room temperature. After dye loading and washing, the
coverslips weremounted in the bath containingHEPES buffer, andCa2
waves were evoked mechanically by touching a single astrocyte with a
micropipette (Cornell-Bell et al., 1990). The changes in fluo-4 AM fluo-
rescence were acquired with 10 Plan objective (Carl Zeiss) at an acqui-
sition speed of 1 frame/1.2 s.
Data analysis
The rate of Ca2 influx (entry) or efflux was obtained by measuring the
initial slope of Ca2 rise or decline, respectively, as illustrated in Fig. 2D,
E, insets. Themaximal value of the normalized fluorescence intensity was
taken as the peak amplitude or influx. To eval-
uate the response time, we determined the
width of the peak at its half-amplitude. The
cumulative fluorescence resulted from the area
under the curve and was derived by integra-
tion. Data analysis was performed withMS Ex-
cel 2003, Origin 7, KaleidaGraph version 4.1,
and ImageJ software.
For the glutamate release analysis, the dF/F0
values of the test group (siNCLX) were ranked
and normalized to siControl to allow compar-
isons between experimental batches and to
accommodate for variations in GDH concentra-
tion and culture conditions. In associated exper-
iments, similar ranking of Ca2cyt dF/F0 was
done for consistency. Resulting proportions are
expressed as means  SEM. Data analysis was
performed with MS Excel 2003, GB-Stat, and
V imaging software (Digital Optics).
A custom-made algorithm programmed in
Cwas used to calculate theCa2wave veloc-
ity at which the wave reached each cell. For this
purpose, two parameters were determined; (1)
the time at which the increase in cytoplasmic
Ca2 was observed in a given cell and (2) the
distance of this cell from the stimulation point.
The first parameter was measured by a peak de-
tection algorithm in the derivative of the mean
intensity values over time in the labeled regions.
Cell detection was done by first obtaining a bi-
nary mask of the SD projection of the time stack
using automatic triangle thresholding (Zack et
al., 1977). Individual cellswere identified thereaf-
ter by a two-pass connected-component labeling
(Shapiro and Stockman, 2001).
Statistics
All experiments were done at least three times
using astrocytic cultures originating from inde-
pendent cell preparations. Data are presented as
mean with SEM for column graphs, with excep-
tion of Figure 3, where we used box plots with
median, interquartile range (25th and 75th per-
centiles), and minimum and maximum values
(whiskers). For the parametrical data, the statisti-
cal significance was evaluated using Student’s t
test, unpaired and double-tailed. For the ex-
periments with more than two test groups to
compare, a multiple parameter one-way
ANOVA test was used followed by Bonferroni
posttest. For the comparison of nonparametric
data, aMann–WhitneyU test or Kruskall–Wallis
test followed by Bonferroni correction andMan-
n–WhitneyU test pair comparisons were used to
evaluate the statistical significance (*p  0.05;
**p 0.01; ***p 0.001).
Results
NCLX is enriched in the mitochondria of astrocytes
Recently, NCLX has been identified as the mitochondrial Na/
Ca2 exchanger in several cell types (Palty et al., 2010; Kim et al.,
2012). To determine whether NCLX is the mitochondrial ex-
changer in astrocytes, we first evaluated NCLX expression in ly-
sates from cultures of cortical astrocytes byWestern blot analysis.
Consistent with the previous studies (Palty et al., 2010), a
major band of 60 kDa and a fainter band at 100 kDa re-
lated to the SDS-stable NCLX dimer were detected. The 60
kDa band was also detected in brain lysates from newborn
Figure 1. A, immunoblot analysis of NCLX expression in brain extracts of newborn mice, primary murine astrocytes, and the
murine astrocytoma cell line GL261 (top). GAPDH serves as an internal loading control (bottom). B, NCLX is enriched in the
mitochondria of astrocytes. NCLX expression in indicated cellular compartments: total, crude ER, cytosol, plasmamembrane (PM),
ER, and mitochondria (Mito)-enriched fractions (top). The membranes were stripped and reprobed for PM (N-cadherin), ER
(Sec-62), and mitochondrial (ANT) markers (bottom). C, Astrocytes are viable after 100% efficient siRNA transfection. Top row
showsuntreated control astrocytes (no siRNA); bottomrowshowsastrocytes treatedwith siGLOand siNCLX (siGLO siNCLX). Left:
Astrocytes accumulated calcein (green), indicating their viability. Nuclei are marked with Hoechst 33342 in blue. Right: Red
fluorescence of the same area; untreated astrocytes display dim autofluorecence, whereas siRNA (siGLO SiNCLX)-treated cells
showpunctate stain, consistentwith intracellular accumulationof the transfectionmarker siGLO. Scalebar, 20m.D, Quantitative
RT-PCR analysis after cotransfection with mtRP and siNCLX or siControl, respectively. Untreated and mock-treated (tranfection
agent only) cells were used as additional controls. Experiment was performed four times, each in triplicate. Values are given as
meanswith SEM(*p0.05,Wilcoxon-Mann–WhitneyU test).E, Immunoblot analysis showingNCLXexpression inuntreatedand
mock-treated astrocytes, or transfected with siControl or siNCLX (top). GAPDH serves as an internal loading control (bottom).
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mice and in an astrocytoma cell line GL261, whereas the 100
kDa band was not detectable in brain homogenate, but was
present in GL261 cells (Fig. 1A).
To analyze NCLX expression in different cellular compart-
ments, we performed subcellular fractionation of cultured astro-
cytes and determined NCLX expression using Western blot
analysis. The fractions were counterstained with organelle-
specific markers (Fig. 1B) to determine the separation quality of
the fractions. Total, crude ER, and ER-enriched fractions re-
vealed a faint band at 60 kDa, whereas no band was visible in
the plasma membrane or cytosolic fractions. Interestingly, the
mitochondrial fraction showed a strong NCLX-positive band of
slightly reducedmolecular weight (MW), suggesting that the pas-
sage of NCLX to the mitochondria may be linked to posttransla-
tional proteolysis. Probing with anti-ANT and anti-N-cadherin
antibodies showed a good separation of the mitochondrial and
plasma membrane fractions, respectively. Some degree of ER
cross-contamination was detected in other fractions when prob-
ing the ER marker Sec-62, which is likely related to the physical
cross-linking of the ER with other organelles. Nonetheless, these
data show that the astrocytic Na/Ca2 exchanger NCLX is pri-
marily located in mitochondria.
Molecular silencing of NCLX in astrocytes
To assess the role of NCLX inmodulating astrocytic Ca2 signal-
ing and related functions, the expression of the exchanger was
knocked down with an NCLX-specific mixture of siRNAs
(siNCLX). The fluorescently tagged siRNA siGLO was used as a
cotransfectionmarker to determine optimal conditions for effec-
tive NCLX silencing and to detect transfected cells; calcein live
cell staining was applied to assess cell viability (99%). Cells
treated with siRNA (siGLO  siNCLX) showed punctate red
staining, consistent with intracellular accumulation of the trans-
fection marker siGLO (Fig. 1C, lower right). siGLO fluorescence
was visible in all treated viable cells, showing that cells were suc-
cessfully transfected. The untreated cells showed only dim auto-
fluorescence (Fig. 1C, upper right). All astrocytes showed a
similar accumulation of calcein regardless of whether they were
treated with siRNA or were untreated controls (Fig. 1C, left col-
umn), indicating that the siRNA transfection procedure did not
affect cell viability.
The efficiency of NCLX silencing via siRNA was assessed by
quantitative RT-PCR. Optimal NCLX gene silencing via siRNA
was achieved after 3 d using 10 nM siNCLX. NCLX expression in
the presence of siNCLX was reduced to 24.9  1.3% of the ex-
pression level seen in astrocytes transfected with siControl (Fig.
1D, n  4 experiments, *p  0.05). NCLX mRNA expression
levels remained almost unchanged in cells treated only with the
transfection agent (mock-treated) and in untreated control cells
(84.0 13.9%and 101.7 4.5%, respectively). Consequently, all
experiments were performed on astrocytic cultures 3 d after
siRNA treatment.
NCLX silencing onmRNA level also affected the expression of
the NCLX protein. Western blot analysis of astrocytic extracts
showed a reduction inNCLX expression in astrocytes transfected
with siNCLX compared with astrocytes transfected with siCon-
trol, mock-treated, or untreated cells (Fig. 1E).
NCLX conducts mitochondrial Ca2 efflux in astrocytes
To monitor mitochondrial Ca2 responses, primary astrocytes
were transfected with mtRP (Nagai et al., 2001) Expression of
mtRP reached maximal intensity 48–72 h after transfection.
mtRP expression patternmanifested a typical network-likemito-
chondrial distribution consistent with the strict mitochondrial
localization of this Ca2 reporter (Fig. 2A). Resting mitochon-
drial Ca2 levels in astrocytes transfected with siNCLX were
higher than values obtained from mitochondria of astrocytes
treated with control siRNA (Fig. 2B). Application of ATP (100
M) to astrocytes in Ca2-free HEPES Ringer’s solution for 100 s
elicited a fast rise in themitochondrial Ca2 corresponding to the
Ca2 uptake phase followed by a slower efflux (Fig. 2C, n  10
and 11 experiments for siControl and siNCLX-transfected astro-
cytes, respectively). Mitochondrial Ca2 influx and efflux rates
were determined as described in Materials and Methods and as
indicated in Fig. 2D,E, insets. Comparison of the efflux rates of
the ATP-elicited mitochondrial Ca2 responses in siNCLX-
treated versus siControl-treated cells showed that the mitochon-
drial efflux rate was decreased by 60.2% in siNCLX-treated cells
comparedwith siControl astrocytes (from15.1 1.5 104/s to
6.0 0.6 104/s, n 10 and 11 experiments and n 38 and 64
regions for siControl and siNCLX conditions, respectively,
***p  0.001; Fig. 2D). Moreover, silencing of NCLX signifi-
cantly increased the net mitochondrial Ca2 influx by 28.1%
compared with the siControl condition (from 8.7  0.6 102
to 11.1 0.7 102; n 10 and 11 experiments with siControl-
and siNCLX- transfected astrocytes, respectively, *p  0.05;
Fig. 2E).
The effect of NCLX activity onmitochondrial Ca2 fluxes was
also evident when we used the pharmacological inhibitor of
mitochondrial Na/Ca2 exchange; application of 20 M
CGP37157 resulted in a 62.4% reduction of the ATP-induced
mitochondrial Ca2 efflux in treated astrocytes compared with
cells treated with vehicle (DMSO) (control, 6.4 0.5 104/s,
n  15 experiments and 106 regions of interest; CGP37157-
treated group, 2.5  0.5  104/s, n  11 experiments and 75
regions of interest, ***p  0.001; Fig. 2F,G). The average net
mitochondrial Ca2 influx was increased from 8.6  0.4 
102/s to 12.5 0.9102/s in the presence of CGP37157 (n
15 and 11 experiments with control- and CGP37157- treated
astrocytes, respectively, *p 0.05; Fig. 2H).
NCLX inhibition, either by specific molecular silencing or by
the pharmacological inhibitor, significantly reduced mitochon-
drial Ca2 extrusion, thereby also indirectly increasing the net
Ca2 influx. These data indicate that NCLXmediates mitochon-
drial Ca2 efflux in astrocytes and thereby shapes the mitochon-
drial Ca2 transients.
NCLX shapes the ATP-induced cytosolic Ca2 response
in astrocytes
Mitochondrial Ca2 transport participates in intracellular Ca2
signaling (Hoth et al., 1997; Hajno´czky et al., 1999; Malli et al.,
2003; Parekh, 2008). Our finding thatNCLX is themitochondrial
Na/Ca2 exchanger in astrocytes provides us with a molecular
basis to evaluate howmitochondria respond to or shape cytosolic
Ca2 responses in astrocytes and to determine the role of NCLX
in this process. Astrocytes were cotransfected with siControl or
siNCLX together with the transfection marker siGLO red. After
3 d, cells were loaded with fura-2 AM and cytoplasmic Ca2
signals in response to application of 100MATPweremonitored
from siGLO-red-positive cells, either in Ca2-containing buf-
fer (Fig. 3A–D) or Ca2-free buffer (Fig. 3E–H ). As described
previously (Kresse et al., 2005), application of ATP in Ca2-
containing buffer evoked a rapid increase of cytosolic Ca2
mainly due to InsP3-receptor-mediated release of Ca
2 from the
ER stores, followed by an initial rapid decline and a slower decay-
ing phase. The latter “elevated Ca2 plateau” has been associated
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with Ca2 influx from the extracellular space via store-operated
Ca2 entry (SOCE). The averaged Ca2 transients indicate that
the amplitude of the elevated Ca2 plateau is reduced in NCLX-
silenced astrocytes (Fig. 3A, n  12 and 11 experiments for si-
Control and siNCLX-transfected astrocytes, respectively). To
quantify the effect of NCLX silencing on the cytosolic Ca2 tran-
sient, we determined the cumulative fura-2 AM fluorescence,
peak amplitude, and half-amplitude time in siControl-treated
versus siNCLX-treated astrocytes. The cumulative fluorescence
was reduced by 39.3% in NCLX-silenced astrocytes (Fig. 3B),
whereas the peak amplitude was reduced by 13.4% (Fig. 3C) and
the half-amplitude time of the signal was reduced by 9.8% (Fig.
Figure 2. NCLX mediates mitochondrial Ca 2 efflux in astrocytes. A–E, Primary astrocytes were cotransfected with mtRP and siNCLX or siControl and were analyzed after 3 d. A, Two-photon
microscopy image of astrocytes transfected with mtRP reveals typical mitochondrial pattern of the fluorescent pericam sensor. Scale bar, 10m. B–E, Mitochondrial Ca 2 imaging. B, Resting
mitochondrial Ca 2 levels of astrocytes transfected with siNCLX- or control siRNA, R/R0 values were determined from fluorescent mtRP imaging before application of the stimulus and normalized
to the control condition (n 5 cultures, n 134 and 118 regions), C, Mitochondrial Ca 2 signals of control and siNCLX-transfected astrocytes; 100M ATP in Ca 2-free HEPES buffer was applied
as indicated, averaged curves SEM.D–E, Average rates of themitochondrial Ca 2 efflux (slopes;D) and influx (amplitudes, E) in siControl and siNCLX-transfected astrocytes, comparing n 10
(n38 regions) andn11 (n64 regions) experiments for each condition (***p0.001, *p0.05,Wilcoxon,Mann–WhitneyU test).F–H, Effect of CGP37157onmitochondrial Ca 2 efflux.
F, Mitochondrial Ca 2 signals from control and CGP37157 (CGP)-treated astrocytes. Cells were superfused with Ca 2-free HEPES buffer 20 M CGP37157and 100 M ATP was applied as
indicated; shown are averaged curves SEM. G–H, average rates of mitochondrial efflux (G) and influx (H ). Values are given as means with SEM for n 15 (n 106 regions) and n 11 (n
75 regions) control and CGP37157 experiments, respectively (***p 0.001, *p 0.05, Wilcoxon, Mann–Whitney U test).
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3D) in NCLX-silenced astrocytes compared with siControl-
treated astrocytes (n 12 and 11 experiments, n 294 siControl
and n  222 siNCLX-transfected astrocytes; ***p  0.001,
**p  0.01).
To determine the contribution ofmitochondrial NCLX to the
modulation of Ca2 signals that originate from ER stores, we
superfused cells with Ca2-free buffer and measured ATP-
induced cytosolic Ca2 signals in NCLX-silenced and siControl
astrocytes. ATP triggered a fast rise followed by a fast decline of
the cytoplasmic Ca2 signal as described above. The elevated
plateau phase, seen in Ca2-containing buffer (above) was, as
expected, reduced under Ca2-free conditions. Knock-down of
NCLX revealed a slight but significant reduction of the mean
cumulative Ca2 signal in NCLX-silenced astrocytes, withmedi-
ans shifted from 102.1% in the siControl population to 89.4% in
the NCLX-silenced astrocytes (***p  0.001; Fig. 3F). The rep-
resentation of cumulative Ca2 responses as median and inter-
quartile ranges revealed thatNCLX silencing ismore pronounced
in the lower quartiles of the data (25 th percentile of the box plot):
in those cells with overall lower cumulative Ca2 responses, the
shift was from 79% in the nonsilenced condition to 47.4% after
NCLX knock-down (Fig. 3F).
These results indicate that stimulus-induced cytoplasmic
Ca2 signals in astrocytes, in particular those caused by the entry
of Ca2 from the extracellular space versus Ca2 release from the
ER store, are distinctly modulated by the activity of the mito-
chondrial Na/Ca2 exchanger NCLX.
NCLX activity modulates the store-operated Ca2entry
in astrocytes
SOCE is an important Ca2 influx pathway in nonexcitable cells
such as astrocytes (Kresse et al., 2005; Pivneva et al., 2008;
Verkhratsky et al., 2012). Observations in other cell types show-
ing that the mitochondrial Ca2 shuttling machinery is essential
to sustaining the activity of SOCE (Hoth et al., 1997; Malli et al.,
2003; Parekh, 2008, and the reduction of the Ca2-elevated pla-
teau phase seen in the ATP-induced Ca2 signal in NCLX-
silenced astrocytes (described above) prompted us to determine
the specific influence of mitochondrial NCLX on Ca2 influx
through the SOCE pathway in astrocytes.
To quantify SOCE activity, we used a previously described
protocol. Briefly, ER stores were depleted by application of ATP
in the absence of extracellular Ca2. Cells were then superfused
withCa2-containing buffer, which resulted in aCa2 influx due
to SOCE activity (Kresse et al., 2005; Fig. 4A). The amplitude of
SOCE responsemeasured at the steady phase was decreased from
100.0  5.1% to 59.9  3.1% after silencing of NCLX (n  9
experiments; n  175 and 131 cells for siControl and siNCLX-
transfected astrocytes, respectively, ***p 0.001; Fig. 4B).More-
over, the SOCE rate (reflected by the slope of the influx phase)
was reduced from 100.0 3.6% to 68.0 3.7% by NCLX silenc-
ing (***p 0.001; Fig. 4C). A similar impairment on SOCE func-
tion was found in astrocytes superfused with 20 M CGP3715.
The drug reduced SOCE amplitude by 25.5% and the SOCE rate
by 34.2% compared with vehicle-treated control (n  8 and 7
Figure 3. NCLXmodulates ATP-induced Ca 2 responses in astrocytes. Primary astrocytes were cotransfected with siControl or siNCLX and siGLO red indicator. Cells were loaded with fura-2 AM
and changes in cytoplasmic Ca 2 signals were monitored from siGLO-red-positive cells. A, E, Recording of average fura-2 AM fluorescence for control and siNCLX-transfected astrocytes in
Ca 2-containing buffer (A) and Ca 2-free buffer (E); 100M ATP was added as indicated, averaged curves SEM. B–D, Statistical analysis of the recordings shown in A: cumulative response (B),
amplitudes (C), and half-amplitude time (D) of the ATP-evoked Ca 2 responses. Values are given asmeanwith SEM (n 12 experiments, n 294 cells for control, and n 11 experiments, n
222 cells for siNCLX-transfected astrocytes, respectively; ***p 0.001, **p 0.01, Wilcoxon, Mann–Whitney U test). F, Box-plot chart of the cumulative Ca 2 responses corresponding to
recordings in E indicating median (dark line), interquartile range (box), and minimum and maximum of the values (whiskers) (***p 0.001, Wilcoxon, Mann–Whitney U test).
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experiments, n  376 and 425 cells for control and CGP37157-
treated astrocytes, ***p  0.001; Fig. 4D–F). Similarly, applica-
tion of the protonophore FCCP, which leads to a collapse of
membranepotential andadiminishedcalcium-bufferingcapacityof
mitochondria, caused reductions in both the SOCE amplitude
and rate (Fig. 4D–F). These results suggest that mitochondrial
Ca2 shuttling, and in particular NCLX activity, is of major im-
portance for the regulation of Ca2 influx into the cell through
SOCE.
We next investigated whether Ca2 influx via the SOCE path-
way evokesmitochondrial Ca2 transients and howNCLX activ-
ity regulates this cross talk. We adapted the Ca2 re-admission
protocol described above to mtRP-expressing astrocytes and de-
termined mitochondrial Ca2 transients. In this set of experi-
ments, we measured only the wavelength F430 of the mtRP signal
because ratiometric measurements of mtRP fluorescence F480/
F430 during SOCE for unknown reasons displayed a decrease in
the signal-to-noise ratio. SOCE evoked a fast rise in mitochon-
Figure 4. NCLX controls SOCE in astrocytes.A–C, Imagingof cytosolic Ca 2 in fura-2AM-loadedprimarymurine astrocytes. Astrocyteswere cotransfectedwith siControl or siNCLX and siGLO red indicator.
Cellswereperfused inCa2-freeHEPESbufferand100MATPwasappliedtoemptyERCa2 stores; then5mMCa2wasre-addedas indicatedbythebar totrigger theactivationofSOCE.A, Tracesofaverage
fura-2AMfluorescence(normalizedaverages)duringSOCE.B–C,Amplitudes(B)andratesofSOCE(C) insiControl(n9,n175)andsiNCLX-transfectedastrocytes(n9,n131).Valuesaregivenasmean
withSEM(***p0.001,Wilcoxon,Mann–WhitneyU test).D–F,UntransfectedastrocyteswereperfusedinCa2-freeHEPESbufferwithout(Control)orwith20MCGP37157orwith1MFCCP.Afteradding
100MATPtoemptytheERstores,5mMCa2wasaddedas indicated.D,MeanCa2 responsecurveofallexperiments (normalizedaverages).E–F, Statisticalanalysisof theamplitudes(E)andSOCErates (F )
in astrocytes treatedwith CGP37157(CGP), FCCP, orwithout anydrug (Control). Values are given asmeanwith SEMsummarized fromn8 (n376 cells),n7 (n425 cells), andn5 (n168 cells)
experiments for control, CGP37157, and FCCP-treated astrocytes, respectively (***p 0.001, Kruskal-Wallis rank-sum test followed by Bonferoni’s posttest and Wilcoxon test pair comparisons). G–J,
SOCE-inducedmitochondrial Ca 2 signals in astrocytes cotransfectedwithmtRPand siControl or siNCLXusing the sameparadigmdescribed inA.G, Representative curve showing theaveragedmitochondrial
Ca 2 response.H–J,RatesofthemitochondrialCa 2efflux(H ), influx(I ),andcumulativefluorescence(J ) fromn9experiments(n59andn43regionsof interestforsiControl-andsiNCLX-transfected
astrocytes, respectively; ***p 0.001, Student’s t test for unpaired samples and two-tailed andMann–WhitneyU test).
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drial Ca2 signal followedby a gradual efflux (Fig. 4G). InNCLX-
silenced astrocytes, mitochondrial Ca2 efflux rate was clearly
reduced compared with siControl-transfected cells (1.67 
0.22  104/s and 0.28  0.26 104/s, respectively, n  9
experiments; ***p 0.001; Fig. 4H). Concomitantly, upon acti-
vation of SOCE, the net influx of Ca2 into themitochondria was
increased by 48.8% (***p  0.001; Fig. 4I) and the cumulative
mitochondrial Ca2 signal was elevated by 60.3% (***p 0.001;
Fig. 4J) in NCLX-silenced astrocytes compared with the nonsi-
lenced control.
These results indicate that an active cross talk exists between
SOCE andmitochondria and that Ca2 extrusion throughNCLX is
crucial for maintaining a strong SOCE activity in astrocytes.
NCLX- and Ca2-dependent glutamate release
from astrocytes
Todetermine the impact ofNCLXonCa2-dependent functions of
astrocytes, we studied the secretion of glutamate via the exocytotic/
vesicular pathway induced bymechanical stimulation of astrocytes,
which involves an increase of cytosolic Ca2 (Innocenti et al., 2000;
Hua et al., 2004; Montana et al., 2004). Mitochondria modulate the
magnitude of thismechanically induced excitability (Reyes andPar-
pura, 2008). Interestingly, the pharmacological inhibitor of the mi-
tochondrial Na/Ca2 exchanger, CGP37157, has been shown
previously to reducemechanically inducedCa2 responses and glu-
tamate release from rat solitary astrocytes in vitro (Reyes and Par-
pura, 2008). In the present study,we assessedwhether themolecular
silencing of NCLX produced similar effects on astrocytic Ca2 ex-
citability and gliotransmission.
Astrocytes were transfected with the transfection marker
siGLO, along with either siNCLX or a nontargeted siRNA in
the control group and then loaded with fluo-3 AM to measure
cytosolic Ca 2. Similar to the purinergic receptor stimulation
described above, mechanical stimulation caused an initial tran-
sient Ca2 elevation (n  15; peak dF/F0  478  43%; **p 
0.01, paired t test) followed by a slowly decaying response in
control solitary astrocytes transfected with the nontargeted
siRNA (Fig. 5A). The transient peak was described to indicate the
Ca2 entry into the cytosol predominately from the ER store and
from the extracellular space (Hua et al., 2004; Malarkey et al.,
2008). Our data revealed a twofold decrease in both the peak (n
15; peak dF/F0  283  52%) and a strong, fivefold decrease in
cumulative cytosolic Ca2 levels in siNCLX-treated cells (**p 
0.01,Mann–WhitneyU test; Fig. 5A–C). The knock-downofNCLX
had a much larger inhibitory effect on the Ca2 response than the
Figure 5. NCLXmediates increase of cytosolic Ca 2 and exocytotic glutamate release in astrocytes after mechanical stimulation. A–C, Cytosolic Ca 2measurements. A, Time lapse of average
fluo-3AMfluorescence, reportingon changes in cytoplasmic Ca 2, in solitary astrocytes transfectedwith either siControl or siNCLX in response tomechanical stimulation; all cellswere cotransfected
with the transfectionmarker siGLO.B, Normalized fluo-3AMpeak.C, Cumulative fluorescencevaluesofmechanically stimulated solitary astrocytes inA.D–F, Extracellular glutamatemeasurements.
D, Average kinetics of extracellular NADH fluorescence showingmechanically induced changes in extracellular glutamate surrounding somata of solitary astrocytes that were transfected as in A. E,
F, Normalized peak (E) and cumulative glutamate (Glut; F ) release from mechanically stimulated solitary astrocytes in D. Solitary astrocytes transfected with siNCLX displayed significantly
(Mann–WhitneyU test, **p 0.01) reduced increase inmechanically induced Ca 2 signals and glutamate release comparedwith siControl-transfected cells. The points and bars representmeans
with SEMs of measurements from individual astrocytes (n 15); Arrows in A and D represent the time when mechanical stimulation was applied to the cells.
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pharmacological inhibition of this exchanger by CGP37157, as de-
scribed previously (Reyes and Parpura, 2008).
We next investigated the role of NCLX in Ca2-dependent
exocytotic glutamate release from astrocytes. We used a GDH-
linked assay based on accumulation of the fluorescent product
NADH (Hua et al., 2004;Montana et al., 2004).Mechanical stim-
ulation of the siControl-treated, solitary astrocytes evoked gluta-
mate release, as indicated by a transient increase in NADH
fluorescence (n 15; peak dF/F0 50 11%; **p 0.01, paired
t test; Fig. 5D), corresponding to glutamate surrounding the as-
trocytic somata. We observed a significant decrease in both nor-
malized peak (n 15; peak dF/F0 47 6%) and particularly in
cumulative fluorescence intensity for glutamate release. After
stimulation, basal levels of glutamate release was lower, when
NCLX expression was knocked down when compared with the
siControl group (**p 0.01, Mann–Whitney U test; Fig. 5E,F).
These data indicate that NCLX plays an essential role in medi-
ating cytosolic Ca2responses in astrocytes required for exocy-
totic glutamate gliotransmission.
Mechanically induced astrocytic Ca2
waves are not affected by the activity
of NCLX
Ca2 waves in astrocyte networks consti-
tute a form of intercellular communica-
tion and provide astrocytes with a specific
form of excitability. In cultured astro-
cytes, Ca2 signals can spread to neigh-
boring cells and can propagate as a wave
through many cells (Cornell-Bell et al.,
1990; Dani et al., 1992; Schipke et al.,
2002). Although different mechanisms
have been described to account for the in-
duction and maintenance of intercellu-
lar astroglial Ca2 waves (Scemes and
Giaume, 2006), there is nothing known so
far on the role of mitochondria in the
maintenance of the intercellullar astro-
cytic Ca2waves andwhetherCa2 efflux
through NCLX contributes to the control
of wave propagation in an astrocytic
monolayer.We thereforemeasured veloc-
ities of Ca2 waves in fluo-4 AM-loaded
astrocytes that had been treated with siN-
CLX or control siRNA (Fig. 6A). An astro-
cytewithin themonolayerwasmechanically
stimulated, asdescribedabove, andwaveve-
locitywas calculated for each cell by an algo-
rithm that measures the distance from the
stimulation point and the time at which the
wave reached a given cell. Although the av-
eragedvelocity of theCa2wavewas 23.9
3.3 m/s for siControl astrocytes, and
18.8 2.3 m/s on average for the NCLX-
silenced astrocytes, it was not significantly
different (Fig. 6B). A wave was initiated as a
rapid onset, followed by centrifugal propa-
gationwith almost linear velocity. The aver-
aged time course of the waves is shown in
Figure 6C. Themean data points were fitted
to the following power functions: in
siControl-treated astrocytes, distance
82  6.7  time0.35  0.02, R 2  0.92,
and in NCLX-treated astrocytes, dis-
tance 74 6.6 time0.36  0.02, R2 0.82). The slight reduc-
tion in the Ca2 wave velocity that we observed in NCLX-
silenced astrocytes was not significant, which suggests that the
activity of the mitochondrial exchanger only marginally, if at all,
affects the Ca2 signaling machinery contributing to propaga-
tion of intercellular Ca2 waves in astrocytes.
NCLX participates in control of astrocytic wound healing
in vitro
Astrocyte migration and proliferation represent important cellu-
lar aspects of the brain’s response to injury and during regenera-
tion. Intracellular Ca2 signaling is critical to the regulation of
these cellular responses (Xu et al., 2004; Valero et al., 2008;Wei et
al., 2009; Feldman et al., 2010). Therefore, we investigated
whether the mitochondrial Na/Ca2 exchanger NCLX affects
these functional parameters in astrocytes.
To assess the effect of NCLX on astrocytic wound healing, we
adapted an in vitro assay described previously (Ko¨rnyei et al.,
2000; Matyash et al., 2002). Monolayers of astrocytes that had
Figure6. NCLXdoes not control the velocity ofmechanically evokedCa 2waves in astrocytes.A, Ca 2waveswere inducedby
mechanical stimulation in confluent astrocyte cultures, transfected with siControl or siNCLX, and loaded with fluo-4 AM to image
cytosolic Ca 2. A, Series of subtraction images showing the concentric propagation of a Ca 2 wave as induced by poking an
astrocytewith amicropipette (bright field image, top).B, For each experiment, Ca 2wavepropagation velocitywas calculatedby
averaging the velocities at which the Ca 2wave reached each of the cells on a coverslip. (Wilcoxon, Mann–Whitney U test, p
0.05, n 5 astrocytic preparations, n 20 and 28 coverslips for control and siNCLX, respectively). C, Average time course of the
propagation of the Ca 2wave. Thewavewas initiated as a fast burst that propagated centrifugally close to a linear velocity.Mean
data points could be fitted to a power function: distance A timeb. For siControl-treated astrocytes, A 82 6.7m and
b 0.35 0.02 (R 2 0.92), and for siNCLX-treated astrocytes, A 74 6.64m and b 0.36 0.02 (R 2 0.82). The
values for A and b are given as mean SD. Values in the graph showmean SEM. Fitting curves are presented as dashed lines.
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either been treated with NCLX siRNA or
with control siRNA, as well as mock-
transfected and untreated astrocytes, were
scratched as indicated in Figure 7B and
the cell-free area was measured immedi-
ately after scratching as described by
Geba¨ck et al. (2009) (Fig. 7A). Thereafter,
repopulation was analyzed repeatedly
48–72 h after scratching until the wound
area was closed by at least two-thirds in the
untreated control (endpoint).Molecular si-
lencing of NCLX with siRNA significantly
impaired the astrocytic ability to repopulate
the cell-free area (Fig. 7B,C). Although the
scratch was closed by more than two-thirds
after 48–72 h in siControl cultures, it re-
mained much larger when NCLX was in-
hibited: the mean open wound area in
NCLX-silenced astrocytes was 48.5 2.6%
on average compared with 24.6 2.5% for
the siControl conditions (n  3 experi-
ments, n 20 scratches, ***p 0.001; Fig.
7C), and these observationswere confirmed
in cultures treated with 20 m CGP37157
throughout the regrowth phase (data not
shown), indicating that NCLX activity is
crucial for astrocytic migration and wound
closure in vitro.
To assess whether NCLX exerts an ef-
fect on astrocyte proliferation, we per-
formed cell proliferation assays based on
BrdU incorporation in noninjured cul-
tures. Astrocyte proliferation was de-
creased by 38.6% in NCLX-silenced
astrocyte cultures compared with astro-
cytes transfected with nontargeted siRNA
(siControl, n  3 experiments, n  15
wells, ***p  0.001; Fig. 7D). A possible
harmful side effect of the transfec-
tion procedure can be excluded because
the proliferation in the siControl and
mock-transfected cultures was not im-
paired compared with the untreated
control astrocytes.
These findings indicate that themitochondrial Na/Ca2 ex-
changer NCLX is involved in the control of astrocytic wound
closure and proliferation.
Discussion
Mitochondria are critically involved in Ca2 handling in astrocytes,
therebymodifying astrocytic functions (Verkhratsky et al., 2012). In
the present study, we addressed the specific role of NCLX in shap-
ing astrocytic mitochondrial and cytoplasmic Ca2 signals
and studied its impact on Ca2-dependent astrocyte func-
tions. We show that NCLX, which is enriched in astrocytic
mitochondria, mediates Ca 2 extrusion from mitochondria.
In addition, NCLX predominately modulated the SOCE path-
way, whereas its effect on the ER-dependent Ca2 release was
minor. Therefore, NCLX activity has a major impact on modu-
lating cytoplasmic Ca2signals in astrocytes, as well as their func-
tional output, exocytotic glutamate release, wound closure, and
proliferation, but does not significantly influence the propaga-
tion of mechanically induced Ca2 waves in astrocytic
monolayers.
Our immunochemical approach verified that the NCLX protein
is expressed in astrocytes and occurs as an60 kDa and an100
kDa form that is consistently related to an SDS-resistant NCLX
dimer (Palty et al., 2004; Palty et al., 2006). Comparison of NCLX
expression in different organelle-enriched fractions of astrocytes re-
vealeda strongenrichmentofNCLXin themitochondria, indicating
that it is primarily located in theseorganelles.TheMWofmitochon-
drial NCLX, interestingly, was slightly reduced to 50 kDa com-
pared with the other cellular compartments. Although the
physiological role of such processing is not yet clear and we cannot
rule out whether NCLX cleavage occurred during mitochondrial
isolation, the reduction in MW is consistent with the sensitivity of
NCLX to mitochondrial proteases such as mitochondrial calpains
(Kar et al., 2009; Smith and Schnellmann, 2012). Alternatively, be-
cause our antibody is targeted to the C-terminal domain of NCLX,
cleavage is likely tooccuron theNH3-terminalNCLXdomains.The
N-terminal domains usually harbor the mitochondria-targeting
peptide that can be cleaved during mitochondrial insertion (Moss-
Figure7. NCLXparticipates inastrocytic invitrowoundhealingandproliferation.A, Confluentastrocyticmonolayerswerescratchedas
described in theMaterials andMethods, andphase contrast imageswereacquiredat0h (top row)andafter48–72h (bottomrow)at low
magnification. Left column shows raw images and right column shows the same images after analysiswith T-scratch software. Dark gray
areas correspond to theopenwoundarea; values at the endpoint arenormalized to a100%area at the startingpoint (0h). Scale bar, 100
m.B, Scheme exemplifying how scratches (white lines)were applied to astrocytemonolayers (gray areas). Black frames correspond to
theanalyzedareasof interest.C, Percentageofopenwoundarea inmonolayers thatwereuntransfected,mock-transfected,or transfected
with siControl or siNCLX (n 3 cultures, n 18, 16, 20, and 20 scratches, respectively). Values are given as means with SEM (***p
0.001, Student’s t test for unpaired samples, two-tailed). D, BrdU incorporation into proliferating astrocytes that were untransfected,
mock-transfected,ortransfectedwithsiControlorsiNCLX,givenaspercentageproliferationnormalizedtocontrol(n3experiments,n
15wells; ***p 0.001,Mann–WhitneyU test).
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mann et al., 2012). Although these mechanisms need to be investi-
gated further, they raise interesting questions regarding
posttranslational regulation of NCLX inmitochondria.
NCLXmodulates glial Ca2 signaling
An important finding of our study is that NCLX activity pro-
motes SOCE in astrocytes. Sustained Ca2 influx through SOCE
results in prolonged intracellular Ca2 transients that are partic-
ularly important in controlling slow cellular processes such as
secretory activity and cell proliferation (Hoth et al., 1997;
Golovina, 1999; Golovina et al., 2001; Berridge et al., 2003).
Several studies have documented a pivotal role of the mito-
chondrial exchanger in the replenishment of the ER Ca2 stores
(Arnaudeau et al., 2001; Malli et al., 2005; Kim et al., 2012). We
found that ER Ca2 release, which can be considered an indica-
tive value for ER Ca2 content, was not much altered by the
knock-down of NCLX expression. Although the molecular basis
for this relatively minor influence of NCLX on ER Ca2 needs to
be explored further, it may be related to the major role of SERCA
in refilling the astrocytic Ca2 stores, even under NCLX defi-
ciency. In addition, transfer of Ca2 from the mitochondria to
the ER Ca2 stores is facilitated by the tight physical interactions
mediated by an ER–mitochondria-tethering protein complex
and direct Ca2 transport through these compartments via the
voltage-dependent anion channels (Szabadkai et al., 2006; Korn-
mann et al., 2009; de Brito and Scorrano, 2010). Our results
suggest that such cross talk between the the ER andmitochondria
is relatively weak in astrocytes. This assertion is consistent with
our findings that the strong cytosolic Ca2 response triggered by
ER Ca2 release was followed by only a modest mitochondrial
Ca2 transient compared with a much stronger mitochondrial
Ca2 transient triggered by Ca2 influx into the cells. The latter
effect suggests a stronger interaction of NCLX with the SOCE
pathway. It is not surprising that astrocytic intracellular Ca2
dynamics are inherently linked to those of Na (Kirischuk et al.,
2012). Therefore, in addition to obvious exchange of these ions
via NCLX, cytoplasmic Na concentrations would also be af-
fected by diverse plasma membrane receptors and transporters
involved in Na exchange, among them SOCE and/or P2XRs,
and the cytosolic Na load thus affects a multitude of astroglial
homeostatic functions (Kirischuk et al., 2012).
Mitochondrial metabolism is likely to be affected by the activ-
ity of NCLX, because Ca2 activates several enzymes of the Krebs
cycle (Szabadkai and Duchen, 2008). NCLX, by accelerating mi-
tochondrial Ca2 shuttling, increases the duration of mitochon-
drial Ca2 transients and thereby is likely to enhance ATP
production.
NCLX activity differentially affects migration/proliferation
We used an in vitromodel to study the impact of NCLX function
on the ability of astrocytes to populate a cell-free area as a model
for wound healing. The repopulation of the cell-free “wound”
area is primarily due to astrocyte proliferation, although migra-
tion does also contribute to this process (Ko¨rnyei et al., 2000). A
role of SOCE in wound closure has been proposed previously
(Rao et al., 2006). Our study strongly suggests thatmitochondrial
Ca2 transfer through NCLX is essential to facilitate SOCE, and
therefore may affect astrocytic proliferation and the regrowth of
the astrocytes into the denuded areas of the wound. Although the
downstream mitogenic signaling pathways that link the Ca2
response to migration and proliferation still need to be investi-
gated, earlier studies have highlighted the role of the mitochon-
drial exchanger in activating the PI3 kinase pathway by
accelerating SOCE-related cellular Ca2 rise (Feldman et al.,
2010).
NCLX activity does not affect astrocytic Ca2
wave propagation
Propagating Ca2waves are a major communication pathway of
the astrocytic network and of neuron–astrocyte communication.
Different mechanisms account for the induction and mainte-
nance of intercellular astroglial Ca2 waves. These involve the
release of gliotransmitters, as well as direct diffusion of InsP3
through gap junctions into neighboring astrocytes, where it acti-
vates InsP3 receptors and subsequent release of Ca
2 from ER
stores (Scemes and Giaume, 2006). On a single-cell level (intra-
cellular Ca2 waves), mitochondrial Ca2 buffering has been
described as an important means to attenuate excess Ca2 levels
at the InsP3R microdomains (Boitier et al., 1999) to keep the
amplification working. However, little is known about the role of
mitochondria in the maintenance of the intercellullar astrocytic
Ca2waves and whether Ca2 efflux throughNCLX contributes
to the control of wave propagation in an astrocytic monolayer.
Our results show that the knock-down of NCLX does not induce
a significant change in astrocyte Ca2wave propagation velocity.
The less dominant role of the mitochondrial exchanger in wave
propagationmay be related to at least two issues. First, the rates of
mitochondrial Ca2 uptake are approximately two orders of
magnitude faster than mitochondrial Ca2 efflux, which spans
over tens of seconds (Fig. 2C; Palty et al., 2010). However, the
propagation of the cytosolic astrocytic Ca2 wave is much more
rapid, thus crossing a single glial cell within less than a second. At
this rate, the contribution of the slowermitochondrial exchanger
to cytosolic Ca2 is predicted to beminimal. Second, in addition,
Ca2 release from the ER is the dominant pathway providing
Ca2 during wave propagation. Because ER Ca2 release is not
strongly affected by the knock-down ofNCLX, it is thus less likely
to play a dominant role in propagation of the Ca2 wave.
NCLX is instrumental in increasing cytosolic Ca2 for
triggering release of gliotransmitter glutamate
Previouswork used a pharmacological approach to assess the role
of the mitochondrial Na/Ca2 exchanger in cytoplasmic Ca2
dynamics in astrocytes: inhibition by CGP37157 resulted in a
reduction of mechanically induced Ca2 responses and gluta-
mate release recorded from cultured rat solitary astrocytes (Reyes
and Parpura, 2008). Themolecular identification ofNCLX (Palty
et al., 2010) now provides a more specific, siRNA-based molecu-
lar tool with which to study its role on mechanically induced
Ca2 responses and glutamate release from astrocytes. Although
our data are consistent with previous pharmacological data, they
provide new insight on the role of the exchanger. Most notably,
the molecular knock-down of NCLX triggered a more profound
inhibitory effect on mechanically induced increase of cytosolic
Ca2and subsequent exocytotic release of glutamate than the
pharmacological approach (Reyes and Parpura, 2008). The rea-
son for the differences between the acute pharmacological versus
the siRNA approach could be the multiple sites of CGP37157
action, among them Ca2 transporters. The molecular knock-
down approach is specific for NCLX, whereas the pharmacolog-
ical approach may partially mask the full effect of the
mitochondrial exchanger on glutamate secretion due to side ef-
fects on other transport molecules. Because vesicular glutamate
transporter 3 and cytoplasmic glutamate levels in astrocytes reg-
ulate the magnitude of exocytotic glutamate release from astro-
cytes (Ni and Parpura, 2009), a possible explanation for
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unparalleled changes in cytoplasmic Ca2 and Ca2-dependent
glutamate release could be that astrocytes lacking NCLX have
less glutamate available for vesicular storage and release.De novo
glutamate synthesis relies on the mitochondrial matrix enzyme
pyruvate carboxylase (Hertz et al., 1999), which is activated by
Ca2(Civelek et al., 1996). However, our observation that the
knock-down of NCLX results in a sustained increase, rather than
a decrease, in mitochondrial free Ca2would not support such a
scenario. Therefore, it is tempting to hypothesize that NCLX, by
modulation of glutamate release from astrocytes, has a role in
synaptic transmission and plasticity at the tripartite synapse.
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